Tanya Durkee Urbach - Sep 6, 2022 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role
Director
Signature
/s/ Antonio Migliarese, Attorney-In-Fact
Stock symbol
CYDY
Transactions as of
Sep 6, 2022
Transactions value $
$0
Form type
4
Date filed
9/8/2022, 09:48 PM
Previous filing
Dec 13, 2021
Next filing
Jan 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CYDY Common Stock 162K Sep 6, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYDY Non-qualified stock option (right to buy) Award $0 +113K $0.00 113K Sep 6, 2022 Common Stock 113K $0.50 Direct
transaction CYDY Non-qualified stock option (right to buy) Award $0 +247K $0.00 241K Sep 6, 2022 Common Stock 247K $0.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As of August 31, 2022, 61,777 shares have vested; the balance will vest in nine equal monthly installments beginning on September 1, 2022, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.